The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Sequencing Market Research Report 2024
Synopsis
mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify both known and novel transcript isoforms, gene fusions, and other features as well as allele-specific expression. mRNA-Seq delivers a complete view of the coding transcriptome that is not restricted by the filter of prior knowledge.
The global mRNA Sequencing market was valued at US$ 2810 million in 2023 and is anticipated to reach US$ 8813.4 million by 2030, witnessing a CAGR of 17.7% during the forecast period 2024-2030.
A significant driver in the mRNA Sequencing market is the rapid advancements in genomics research and the growing interest in studying gene expression at the mRNA level. mRNA sequencing, also known as RNA-Seq, provides a powerful tool for understanding the transcriptome and identifying differentially expressed genes across various biological conditions. However, a notable challenge in this market is the need for data analysis and standardization. Ensuring that researchers can efficiently analyze and interpret the vast amount of mRNA sequencing data generated while addressing potential variations in protocols and data processing poses a significant challenge. Bioinformatics solutions, data analysis pipelines, and data-sharing standards must be continuously developed to facilitate data interpretation and integration, promoting the widespread adoption of mRNA sequencing in genomics research and clinical applications.
This report aims to provide a comprehensive presentation of the global market for mRNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Sequencing.
Report Scope
The mRNA Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify both known and novel transcript isoforms, gene fusions, and other features as well as allele-specific expression. mRNA-Seq delivers a complete view of the coding transcriptome that is not restricted by the filter of prior knowledge.
The global mRNA Sequencing market was valued at US$ 2810 million in 2023 and is anticipated to reach US$ 8813.4 million by 2030, witnessing a CAGR of 17.7% during the forecast period 2024-2030.
A significant driver in the mRNA Sequencing market is the rapid advancements in genomics research and the growing interest in studying gene expression at the mRNA level. mRNA sequencing, also known as RNA-Seq, provides a powerful tool for understanding the transcriptome and identifying differentially expressed genes across various biological conditions. However, a notable challenge in this market is the need for data analysis and standardization. Ensuring that researchers can efficiently analyze and interpret the vast amount of mRNA sequencing data generated while addressing potential variations in protocols and data processing poses a significant challenge. Bioinformatics solutions, data analysis pipelines, and data-sharing standards must be continuously developed to facilitate data interpretation and integration, promoting the widespread adoption of mRNA sequencing in genomics research and clinical applications.
This report aims to provide a comprehensive presentation of the global market for mRNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Sequencing.
Report Scope
The mRNA Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global mRNA Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Sequencing Market Perspective (2019-2030)
2.2 mRNA Sequencing Growth Trends by Region
2.2.1 Global mRNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Sequencing Historic Market Size by Region (2019-2024)
2.2.3 mRNA Sequencing Forecasted Market Size by Region (2025-2030)
2.3 mRNA Sequencing Market Dynamics
2.3.1 mRNA Sequencing Industry Trends
2.3.2 mRNA Sequencing Market Drivers
2.3.3 mRNA Sequencing Market Challenges
2.3.4 mRNA Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Sequencing Players by Revenue
3.1.1 Global Top mRNA Sequencing Players by Revenue (2019-2024)
3.1.2 Global mRNA Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Sequencing Revenue
3.4 Global mRNA Sequencing Market Concentration Ratio
3.4.1 Global mRNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Sequencing Revenue in 2023
3.5 mRNA Sequencing Key Players Head office and Area Served
3.6 Key Players mRNA Sequencing Product Solution and Service
3.7 Date of Enter into mRNA Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Sequencing Breakdown Data by Type
4.1 Global mRNA Sequencing Historic Market Size by Type (2019-2024)
4.2 Global mRNA Sequencing Forecasted Market Size by Type (2025-2030)
5 mRNA Sequencing Breakdown Data by Application
5.1 Global mRNA Sequencing Historic Market Size by Application (2019-2024)
5.2 Global mRNA Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Sequencing Market Size (2019-2030)
6.2 North America mRNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Sequencing Market Size by Country (2019-2024)
6.4 North America mRNA Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Sequencing Market Size (2019-2030)
7.2 Europe mRNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Sequencing Market Size by Country (2019-2024)
7.4 Europe mRNA Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Sequencing Market Size (2019-2030)
8.2 Asia-Pacific mRNA Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Sequencing Market Size (2019-2030)
9.2 Latin America mRNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Sequencing Market Size by Country (2019-2024)
9.4 Latin America mRNA Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Sequencing Market Size (2019-2030)
10.2 Middle East & Africa mRNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific mRNA Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in mRNA Sequencing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina mRNA Sequencing Introduction
11.2.4 Illumina Revenue in mRNA Sequencing Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) mRNA Sequencing Introduction
11.3.4 QIAGEN (Exiqon) Revenue in mRNA Sequencing Business (2019-2024)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies mRNA Sequencing Introduction
11.4.4 Agilent Technologies Revenue in mRNA Sequencing Business (2019-2024)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche mRNA Sequencing Introduction
11.5.4 Roche Revenue in mRNA Sequencing Business (2019-2024)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare mRNA Sequencing Introduction
11.6.4 GE Healthcare Revenue in mRNA Sequencing Business (2019-2024)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories mRNA Sequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in mRNA Sequencing Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm mRNA Sequencing Introduction
11.8.4 Fluidigm Revenue in mRNA Sequencing Business (2019-2024)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
